Etyqa Tablet, Film Coated
Product Images NDC 59651-425

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Etyqa (NDC 59651-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Estradiolnorethin Fig1)

A line graph depicting plasma concentrations of Estradiol and Estrone over a 24-hour period post-dose. The y-axis shows concentration in pg/ml, and the x-axis shows time in hours. Both hormones show peak levels between 2 and 6 hours, with Estrone reaching higher concentrations than Estradiol before declining over time.*

FDA Label Image

Estradiolnorethin-fig10 (Estradiolnorethin Fig10)

Packaging label for Etyqa (estradiol and norethindrone acetate) tablets USP 0.5 mg/0.1 mg by Aurobindo Pharma Limited. The label displays a blister pack containing 28 film-coated white tablets. It includes storage instructions, dosage reminder, distributor information, and barcode on a green and white background.*

FDA Label Image

Estradiolnorethin-fig11 (Estradiolnorethin Fig11)

Packaging label for Etyqa (estradiol and norethindrone acetate tablets, USP) 0.5 mg/0.1 mg oral film-coated tablets. The label indicates one blister pack containing 28 white tablets. Distributed by Aurobindo Pharma USA, Inc., made in India. The label includes storage instructions and drug strength details.*

FDA Label Image

Estradiolnorethin-fig12 (Estradiolnorethin Fig12)

Packaging label for Etyqa (estradiol and norethindrone acetate) 1 mg/0.5 mg tablets, USP. The label indicates it is an oral, film-coated tablet, supplied in a blister pack containing 28 tablets. The labeler is Aurobindo Pharma Limited, and it specifies prescription use only with storage instructions and barcode included.*

FDA Label Image

Estradiolnorethin-fig13 (Estradiolnorethin Fig13)

Packaging label for Etyqa film-coated tablets with 1 mg estradiol and 0.5 mg norethindrone acetate. The label indicates the package contains 28 white tablets in one blister pack. Distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions and prescription-only status are also visible.*

FDA Label Image

Estradiolnorethin-fig14 (Estradiolnorethin Fig14)

Etyqa estradiol and norethindrone acetate tablets, USP 1 mg/0.5 mg film-coated oral tablets, in a 28-tablet blister pack. The packaging includes dosage information, storage instructions, and is labeled as not child resistant. The product is distributed by Aurobindo Pharma USA, Inc. and made in India.*

FDA Label Image

Fig2 (Estradiolnorethin Fig2)

A pharmacokinetic curve depicting concentration (ng/ml) on the vertical axis and time (hours) on the horizontal axis, showing a peak concentration within the first hour followed by a gradual decline over 24 hours.*

FDA Label Image

Estradiolnorethin-fig3.jpg (Estradiolnorethin Fig3)

Line graph depicting the change in the number of moderate to severe hot flushes per week over 12 weeks. The graph compares three groups: placebo, 1 mg estradiol, and estradiol and norethindrone acetate tablets 1 mg/0.5 mg, showing a larger decrease in hot flushes for the combination tablet group over time.*

FDA Label Image

Estradiolnorethin-fig4.jpg (Estradiolnorethin Fig4)

A line graph comparing the number of moderate to severe hot flushes over a 12-week period between two groups: one taking Estradiol and Norethindrone Acetate Tablets 0.5 mg/0.1 mg and the other taking a placebo. The y-axis represents the number of hot flushes and the x-axis the duration in weeks. The graph shows a decrease in hot flushes for the treatment group compared to the placebo group over time.*

FDA Label Image

Estradiolnorethin-fig5.jpg (Estradiolnorethin Fig5)

A line graph showing the percentage of women over 12 cycles comparing 1 mg Estradiol (E2) tablets and Estradiol and Norethindrone Acetate tablets. The graph depicts a higher percentage increase over cycles for the 1 mg E2 group compared to the combination tablets group.*

FDA Label Image

Estradiolnorethin-fig6.jpg (Estradiolnorethin Fig6)

A line graph comparing the percentage of women over six cycles for Estradiol and Norethindrone Acetate Tablets 0.5 mg/0.1 mg versus placebo. The x-axis represents treatment cycles 1 through 6, and the y-axis shows the percentage of women ranging from 40% to 100%. The graph includes a legend identifying the solid line with diamonds for the active drug and the dashed line with circles for placebo.*

FDA Label Image

Estradiolnorethin-fig7.jpg (Estradiolnorethin Fig7)

A line graph showing percent change over lunar months (28-day cycles) comparing Estradiol and Norethindrone Acetate tablets at 1 mg/0.5 mg dosage, Estradiol 0.5 mg, and placebo across European Union (EU) and United States (US) groups. Error bars indicate variability for each data point over time.*

FDA Label Image

Figure 8 (Estradiolnorethin Fig8)

A dosing calendar illustration for Estradiol and Norethindrone Acetate Tablets USP, 1 mg/0.5 mg. The diagram displays four weekly rows labeled 1 through 4, with each row containing seven circles representing days Sunday through Saturday. Arrows indicate the order of tablet intake, guiding users to start on Sunday and follow the sequence.*

FDA Label Image

Estradiolnorethin-fig9 (Estradiolnorethin Fig9)

Etyqa estradiol and norethindrone acetate tablets, USP 0.5 mg/0.1 mg film-coated oral tablets. The label indicates a 1 blister pack containing 28 white tablets. The product is labeled by Aurobindo Pharma Limited and distributed by Aurobindo Pharma USA, Inc. The label includes usage and storage instructions, barcode, and the NDC 59651-425-87.*

FDA Label Image

Estradiolnorethin-str1.jpg (Estradiolnorethin Str1)

Chemical structure of Estradiol, the active ingredient in Etyqa, a human prescription drug containing estradiol and norethindrone acetate.*

FDA Label Image

Estradiolnorethin-str2.jpg (Estradiolnorethin Str2)

Chemical structure of Norethindrone Acetate, a synthetic progestin used in hormone therapy and contraceptive formulations. The diagram depicts the arrangement of atoms and bonds characteristic of the Norethindrone Acetate molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.